Chlorhexidine gluconate is filed as Antiinfectives and antiseptics for local oral treatment. The sections below restate public label fields stored for this profile.
INDICATIONS AND USAGE Chlorhexidine Gluconate Oral Rinse is indicated for use between dental visits as part of a professional program for the treatment of gingivitis as characterized by redness and swelling of the gingivae, including gingival bleeding upon probing. Chlorhexidine gluconate has not been tested among patients with acute necrotizing ulcerative gingivitis (ANUG). For patients having coexisting gingivitis and periodontitis, see PRECAUTIONS .
CLINICAL PHARMACOLOGY Chlorhexidine gluconate provides antimicrobial activity during oral rinsing. The clinical significance of chlorhexidine gluconate’s antimicrobial activities is not clear. Microbiological sampling of plaque has shown a general reduction of counts of certain assayed bacteria, both aerobic and anaerobic, ranging from 54–97% through six months’ use. Use of chlorhexidine gluconate oral rinse in a six-month clinical study did not result in any significant changes in bacterial resistance, overgrowth of potentially opportunistic organisms or other adverse changes in the oral microbial ecosystem. Three months after chlorhexidine gluconate use was discontinued, the number of bacteria in plaque had returned to baseline levels and resistance of plaque bacteria to chlorhexidine gluconate was equal to that at baseline. Pharmacokinetics: Pharmacokinetic studies with 0.12% chlorhexidine gluconate oral rinse indicate approximately 30% of the active ingredient, chlorhexidine gluconate, is retained in the oral cavity following rinsing. This retained drug is slowly released into the oral fluids. Studies conducted on human subjects and animals demonstrate chlorhexidine gluconate is poorly absorbed from the gastrointestinal tract. The mean plasma level of chlorhexidine gluconate reached a peak of 0.206 mcg/g in humans 30 minutes after they ingested a 300-mg dose of the drug. Detectable levels of chlorhexidine gluconate were not present in the plasma of these subjects 12 hours after the compound was administered. Excretion of chlorhexidine gluconate occurred primarily through the feces (~90%). Less than 1% of the chlorhexidine gluconate ingested by these subjects was excreted in the urine.
WARNINGS The effect of chlorhexidine gluconate on periodontitis has not been determined. An increase in supragingival calculus was noted in clinical testing in chlorhexidine gluconate oral rinse users compared with control users. It is not known if chlorhexidine gluconate use results in an increase in subgingival calculus. Calculus deposits should be removed by a dental prophylaxis at intervals not greater than six months. Anaphylaxis, as well as serious allergic reactions, have been reported during postmarketing use with dental products containing chlorhexidine. See CONTRAINDICATIONS.
CONTRAINDICATIONS This product should not be used by persons who are known to be hypersensitive to chlorhexidine gluconate or other formula ingredients.
Tooth/tongue staining (Very common (brown discoloration)); Altered taste (Common); Increased calculus formation (Common); Oral mucosal irritation (Occasional); Skin irritation (surgical prep) (Occasional); Allergic contact dermatitis (Rare); Anaphylaxis (Very rare)
The most common side effects associated with chlorhexidine gluconate oral rinses are: 1) an increase in staining of teeth and other oral surfaces; 2) an increase in calculus formation; and 3) an alteration in taste perception; see WARNINGS and PRECAUTIONS. Oral irritation and local allergy-type symptoms have been spontaneously reported as side effects associated with use of chlorhexidine gluconate rinse. The following oral mucosal side effects were reported during placebo - controlled adult clinical trials: aphthous ulcer, grossly obvious gingivitis, trauma, ulceration, erythema, desquamation, coated tongue, keratinization, geographic tongue, mucocele, and short frenum. Each occurred at a frequency of less than 1.0%. Among post marketing reports, the most frequently reported oral mucosal symptoms associated with chlorhexidine gluconate oral rinse are stomatitis, gingivitis, glossitis, ulcer, dry mouth, hypesthesia, glossal edema, and paresthesia. Minor irritation and superficial desquamation of the oral mucosa have been noted in patients using chlorhexidine gluconate oral rinse. There have been cases of parotid gland swelling and inflammation of the salivary glands (sialadenitis) reported in patients using chlorhexidine gluconate oral rinse.
Oral rinse (0.12%): 15 mL swish for 30 seconds twice daily after brushing. Surgical prep (2–4%): apply to skin per institutional protocol, allow to dry completely. Do NOT use near eyes, ears, or meninges. Flammable when dry — allow full drying before draping/electrocautery.
Anionic surfactants (sodium lauryl sulfate in many toothpastes): neutralizes chlorhexidine activity — wait 30 minutes between use. Do not mix with other antiseptics. Nystatin oral suspension: reduced chlorhexidine effectiveness.
According to its FDA label, Chlorhexidine gluconate is approved for: INDICATIONS AND USAGE Chlorhexidine Gluconate Oral Rinse is indicated for use between dental visits as part of a professional program for the treatment of gingivitis as characterized by redness and swelling of the gingivae, including gingival bleeding upon probing. Chlorhexidine… For medical advice, please talk to your prescriber or pharmacist.
Chlorhexidine gluconate belongs to the Antiinfectives and antiseptics for local oral treatment class of medications.
The FDA label lists Chlorhexidine gluconate as: HOW SUPPLIED Chlorhexidine Gluconate Oral Rinse USP 0.12% is supplied as a blue liquid in the following sizes: 16 fluid ounce or 1 pint (473 mL) (NDC 0374-5080-02) amber plastic bottles with child-resistant dispensing closures. 1/2 fluid ounce (15 mL) (NDC 0374-5080-01) amber plastic unit-dose cups. Store at 20°-25°C (68°-77°F); excursions permitted to 15°-30°C (59°-86°F) [See USP Controlled Room Termperature]. Dispense in original container or in amber glass bottles. What to expect when using Chlorhexidine Gluconate Oral Rinse Your dentist has prescribed Chlorhexidine Gluconate Oral Rinse to treat your gingivitis, to help reduce the redness and swelling of your gums, and also to help you control any gum bleeding. Use Chlorhexidine Gluconate Oral Rinse regularly, as directed by your dentist, in addition to daily brushing. Spit out after use. Chlorhexidine Gluconate Oral Rinse should not be swallowed. If you develop allergic symptoms such as skin rash, itch, generalized swelling, breathing difficulties, light headedness, rapid heart rate, upset stomach or diarrhea, seek medical attention immediately. Chlorhexidine Gluconate Oral Rinse should not be used by persons who have a sensitivity to it or its components. Chlorhexidine Gluconate Oral Rinse may cause some tooth discoloration, or increases in tartar (calculus) formation, particularly in areas where stain and tartar usually form. It is important to see your dentist for removal of any stain or tartar at least every six months, or more frequently if your dentist advises. Both stain and tartar can be removed by your dentist or hygienist. Chlorhexidine Gluconate Oral Rinse may cause permanent discoloration of some front-tooth fillings. To minimize discoloration, you should brush and floss daily, emphasizing areas which begin to discolor. Chlorhexidine Gluconate Oral Rinse may taste bitter to some patients and can affect how foods and beverages taste. This will become less noticeable in most cases with continued use …; oral route. Available strengths and packaging vary by manufacturer.
Our ingest of the FDA label for Chlorhexidine gluconate does not include a Boxed Warning at this time. See the full label on DailyMed for the current, authoritative version.
Public CMS NADAC pricing for Chlorhexidine gluconate is in the range Institutional: $3–$15 per bottle (oral rinse 473 mL) or $5–$25 per surgical prep unit. Retail price varies by pharmacy, insurance, and manufacturer coupons.
The FDA Enforcement Report does not show an active/ongoing recall for Chlorhexidine gluconate in our latest ingest. Recall data can change daily — verify at FDA.gov.
The FDA record lists the approval date for Chlorhexidine gluconate as 1995-12-28.
The FDA label lists Lyne Laboratories, Inc. as a labeler/manufacturer of Chlorhexidine gluconate. Multiple firms may market generics of the same molecule.
The FDA label states: "Other information store at 20-25°C (68-77°F) avoid excessive heat above 40°C (104°F)" Follow the packaging insert for the authoritative guidance.
The FDA label lists a pregnancy category of B for Chlorhexidine gluconate. Pregnancy and lactation decisions should be made with a clinician.
Loading full data from Know Your Drugs Institute…